Loading...

Simona Zompi, MD, PhD

Title(s)Assistant Professor, Medicine
SchoolSchool of Medicine
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Fung M, Zompi S, Seng H, Hollemon D, Parham A, Hong DK, Bercovici S, Dolan E, Lien K, Teraoka J, Logan AC, Chin-Hong P. Plasma Cell-Free DNA Next-Generation Sequencing to Diagnose and Monitor Infections in Allogeneic Hematopoietic Stem Cell Transplant Patients. Open Forum Infect Dis. 2018 Dec; 5(12):ofy301. PMID: 30581881.
      View in: PubMed
    2. Halstead SB, Zompi S. Protective immune responses to dengue virus infection and vaccines: perspectives from the field to the bench. Front Immunol. 2015; 6:75. PMID: 25741345.
      View in: PubMed
    3. Puschnik A, Lau L, Cromwell EA, Balmaseda A, Zompi S, Harris E. Correlation between dengue-specific neutralizing antibodies and serum avidity in primary and secondary dengue virus 3 natural infections in humans. PLoS Negl Trop Dis. 2013; 7(6):e2274. PMID: 23785536.
      View in: PubMed
    4. Parameswaran P, Liu Y, Roskin KM, Jackson KK, Dixit VP, Lee JY, Artiles KL, Zompi S, Vargas MJ, Simen BB, Hanczaruk B, McGowan KR, Tariq MA, Pourmand N, Koller D, Balmaseda A, Boyd SD, Harris E, Fire AZ. Convergent antibody signatures in human dengue. Cell Host Microbe. 2013 Jun 12; 13(6):691-700. PMID: 23768493.
      View in: PubMed
    5. Zompi S, Harris E. Original antigenic sin in dengue revisited. Proc Natl Acad Sci U S A. 2013 May 28; 110(22):8761-2. PMID: 23686453.
      View in: PubMed
    6. Zompi S, Montoya M, Pohl MO, Balmaseda A, Harris E. Dominant cross-reactive B cell response during secondary acute dengue virus infection in humans. PLoS Negl Trop Dis. 2012; 6(3):e1568. PMID: 22448292.
      View in: PubMed
    7. Zompi S, Harris E. Animal models of dengue virus infection. Viruses. 2012 01; 4(1):62-82. PMID: 22355452.
      View in: PubMed
    8. Zompi S, Santich BH, Beatty PR, Harris E. Protection from secondary dengue virus infection in a mouse model reveals the role of serotype cross-reactive B and T cells. J Immunol. 2012 Jan 01; 188(1):404-16. PMID: 22131327.
      View in: PubMed
    9. Williams KL, Zompi S, Beatty PR, Harris E. A mouse model for studying dengue virus pathogenesis and immune response. Ann N Y Acad Sci. 2009 Sep; 1171 Suppl 1:E12-23. PMID: 19751398.
      View in: PubMed
    10. Caraux A, Kim N, Bell SE, Zompi S, Ranson T, Lesjean-Pottier S, Garcia-Ojeda ME, Turner M, Colucci F. Phospholipase C-gamma2 is essential for NK cell cytotoxicity and innate immunity to malignant and virally infected cells. Blood. 2006 Feb 01; 107(3):994-1002. PMID: 16204312.
      View in: PubMed
    11. Zompi S, Colucci F. Anatomy of a murder--signal transduction pathways leading to activation of natural killer cells. Immunol Lett. 2005 Feb 15; 97(1):31-9. PMID: 15626473.
      View in: PubMed
    12. Zompi S, Gu H, Colucci F. The absence of Grb2-associated binder 2 (Gab2) does not disrupt NK cell development and functions. J Leukoc Biol. 2004 Oct; 76(4):896-903. PMID: 15240750.
      View in: PubMed
    13. Zompi S, Couderc LJ, Cadranel J, Antoine M, Epardeau B, Fleury-Feith J, Popa N, Santoli F, Farcet JP, Delfau-Larue MH. Clonality analysis of alveolar B lymphocytes contributes to the diagnostic strategy in clinical suspicion of pulmonary lymphoma. Blood. 2004 Apr 15; 103(8):3208-15. PMID: 15070704.
      View in: PubMed
    14. Legrand O, Zompi S, Perrot JY, Faussat AM, Benderra Z, Chaoui D, Marie JP. P-glycoprotein and multidrug resistance associated protein-1 activity in 132 acute myeloid leukemias according to FAB subtypes and cytogenetics risk groups. Haematologica. 2004 Jan; 89(1):34-41. PMID: 14754604.
      View in: PubMed
    15. Zompi S, Hamerman JA, Ogasawara K, Schweighoffer E, Tybulewicz VL, Di Santo JP, Lanier LL, Colucci F. NKG2D triggers cytotoxicity in mouse NK cells lacking DAP12 or Syk family kinases. Nat Immunol. 2003 Jun; 4(6):565-72. PMID: 12740576.
      View in: PubMed
    16. Zompi S, Viguié F. Therapy-related acute myeloid leukemia and myelodysplasia after successful treatment of acute promyelocytic leukemia. Leuk Lymphoma. 2002 Feb; 43(2):275-80. PMID: 11999558.
      View in: PubMed
    17. Bouscary D, Lecoq-Lafon C, Chrétien S, Zompi S, Fichelson S, Muller O, Porteu F, Dusanter-Fourt I, Gisselbrecht S, Mayeux P, Lacombe C. Role of Gab proteins in phosphatidylinositol 3-kinase activation by thrombopoietin (Tpo). Oncogene. 2001 Apr 26; 20(18):2197-204. PMID: 11402314.
      View in: PubMed
    18. Zompi S, Delfau-Larue MH, Stern M, Blanche P, Lahet C, Farcet JP, Couderc LJ. Lymphoid interstitial pneumonitis in patients with the human immunodeficiency virus: usefulness of alveolar lymphocytes gene by polymerase chain reaction. Arch Intern Med. 2001 Jan 08; 161(1):124. PMID: 11146709.
      View in: PubMed
    19. Zompi S, Legrand O, Bouscary D, Blanc CM, Picard F, Casadevall N, Dreyfus F, Marie JP, Viguié F. Therapy-related acute myeloid leukaemia after successful therapy for acute promyelocytic leukaemia with t(15;17): a report of two cases and a review of the literature. Br J Haematol. 2000 Sep; 110(3):610-3. PMID: 10997972.
      View in: PubMed
    20. Zompi S, Tulliez M, Conti F, Leblond V, Gaulard P, Blanche P, Durand F, Ghandi D, Dreyfus F, Louvel A, Calmus Y, Bouscary D. Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with clonal lymphoproliferative disorders after orthotopic liver transplantation: a report of three cases. J Hepatol. 2000 Mar; 32(3):521-7. PMID: 10735625.
      View in: PubMed
    21. Bouscary D, Jondeau K, Viguié F, Zompi S, Fontenay-Roupie M, Quarre MC, Vassilief D, Dreyfus F, Casadevall N. Aplastic anemia responsive to cyclosporine complicating the evolution of polycythemia vera. Leuk Lymphoma. 1999 May; 33(5-6):607-11. PMID: 10342591.
      View in: PubMed